MRNA short sellers face ~$4.8B paper losses after jump to $159
Moderna (MRNA) short sellers face about $4.8B in paper losses on Wednesday after the stock surges to $159, according to Ortex estimates.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.